This content is machine translated Non-Hodgkin's Lymphoma Bortezomib in previously untreated multiple myeloma. A subanalysis of the VISTA trial was presented at the ASH Congress in New Orleans, showing that a higher cumulative dose of bortezomib resulted in a better outcome in patients…
